The company trades and processes agricultural commodities like pulses, sugar, and grains, sourcing from international markets and selling to wholesalers and retailers in India and abroad.
The company operates in a highly commoditized trading environment where margins are razor-thin at approximately 1%, indicating no pricing power. While they are investing in processing plants to add value, the business currently lacks a durable cost or scale advantage that translates into superior returns.
Management is pivoting capital toward domestic manufacturing and processing facilities in Kolkata and Surat to capture value-addition margins. However, the EPS CAGR of -42.3% suggests that recent reinvestments and the shift in strategy have yet to generate per-share value for owners.
The company's razor-thin margins and high debt load finally collided when interest rates rose or credit tightened, causing the 1.06 interest coverage to collapse into a liquidity crisis. Despite growing revenue, the negative cash conversion cycle drained working capital, while the pivot into unfamiliar textile branding and domestic manufacturing failed to offset the loss of lucrative export quotas. The business eventually became a 'zombie' enterprise, operating solely to service its bank debt and promoter salaries while shareholders watched their equity erode through persistent negative earnings growth.
RichFakir rates Uma Exports Ltd's business quality as poor — 16/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Uma Exports Ltd is trading about 43% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Uma Exports Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Uma Exports Ltd's fair value is about ₹33 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →